Cleared Traditional

K790007 - I TESTOTERONE

K790007 is an FDA 510(k) clearance for I TESTOTERONE, manufactured by Cambridge Nuclear Corp.. The device is a Class 1 Immunology device with product code CDZ cleared through the Traditional 510(k) pathway after a 55-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1979
Decision
55d
Days
Class 1
Risk

K790007 is an FDA 510(k) clearance for the I TESTOTERONE. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Cambridge Nuclear Corp. (Mchenry, US). The FDA issued a Cleared decision on February 26, 1979 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1680 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K790007

510(k) Number K790007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 02, 1979
Decision Date February 26, 1979
Days to Decision 55 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 105d · This submission: 55d
Pathway characteristics
Predicate-based equivalence.

CDZ Device Classification - Class 1, General Controls

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 88
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K790007.
NORDICLAB TESTOSTERONE RIA TEST
K800921 · Nordiclab Intl. · May 1980
TESTOK-125
K800776 · Sorin Biomedica, Fiat, USA, Inc. · Apr 1980
(125I) TESTOSTERONE KIT
K791999 · Radioassay Systems Laboratories, Inc. · Oct 1979
TESTOSTERONE RADIOIMMUNOASSAY KIT 125I
K780792 · The Upjohn Co. · Jun 1978
TESTOSTERONE RIA KIT (125I)
K772191 · Diagnostic Products Corp. · Jan 1978